Aleafia Health Announces the Passing of Director Daniel Milliard
17 Juni 2021 - 3:20PM
Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or
the “Company”), with great regret announces the passing of Daniel
Milliard, a valued member of its Board of Directors.
“We are tremendously sad that our dear friend and colleague
Daniel Milliard has passed away. It was a privilege to serve with
Dan on Aleafia’s board and previously at Emblem, where I witnessed
firsthand his integrity, work ethic, and business acumen,” said
Aleafia Health Director Loreto Grimaldi. “Through decades of
experience as a senior executive and director, Dan provided wise
counsel and a steady hand that will be greatly missed. On behalf of
our board of directors and management, I would like to extend our
deepest condolences to Dan’s wife Maria and family.”
For Investor & Media Relations:
Nicholas Bergamini, VP Investor
Relations1-833-879-2533IR@AleafiaHealth.comLEARN MORE:
www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed
Canadian cannabis company offering cannabis health and wellness
services and products in Canada and with sales and operations in
Australia and Germany. The Company operates medical clinics,
education centres and production facilities for the production and
sale of cannabis.
Aleafia Health owns four significant licensed cannabis
production facilities, including the first large-scale, legal
outdoor cultivation facility in Canadian history. The Company
produces a diverse portfolio of commercially proven, high-margin
derivative products including oils, capsules, edibles, sublingual
strips, and vapes. Aleafia Health operates the largest national
network of medical cannabis clinics and education centres staffed
by MDs, nurse practitioners and educators and operates
internationally in three continents.
Aleafia Health (TSX:AH)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Aleafia Health (TSX:AH)
Historical Stock Chart
Von Apr 2023 bis Apr 2024